α-Cyclodextrin and α-Cyclodextrin Polymers as Oxygen Nanocarriers to Limit Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model

The incidence of heart failure (HF) is increasing worldwide and myocardial infarction (MI), which follows ischemia and reperfusion (I/R), is often at the basis of HF development. Nanocarriers are interesting particles for their potential application in cardiovascular disease. Impaired drug delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Femminò, Saveria, Penna, Claudia, Bessone, Federica, Caldera, Fabrizio, Dhakar, Nilesh, Cau, Daniele, Pagliaro, Pasquale, Cavalli, Roberta, Trotta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414891/
https://www.ncbi.nlm.nih.gov/pubmed/30966247
http://dx.doi.org/10.3390/polym10020211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414891/
https://www.ncbi.nlm.nih.gov/pubmed/30966247
http://dx.doi.org/10.3390/polym10020211

Ejemplares similares